Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Capstone Therapeutics Corp. | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - Capstone Therapeutics Corp. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - Capstone Therapeutics Corp. | exh_311.htm |
| 10-K - FORM 10-K - Capstone Therapeutics Corp. | f10k_022818.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements of Capstone Therapeutics Corp. (formerly OrthoLogic Corp.) of our report dated February 28, 2018 relating to the consolidated financial statements of Capstone Therapeutics Corp. included in this Annual Report (Form 10-K) for the year ended December 31, 2017:
(1) Registration Statement (Form S-8 No. 333-134980) pertaining to OrthoLogic Corp.’s 2005 Equity Incentive Plan
(2) Registration Statement (Form S-8 No. 333-159238) pertaining to OrthoLogic Corp.’s 2005 Equity Incentive Plan
| (3) | Registration Statement (Form S-8 No. 333-196828) pertaining to Capstone Therapeutics Corp.’s 2005 Equity Incentive Plan |
| (4) | Registration Statement (Form S-8 No. 333-205160) pertaining to Capstone Therapeutics Corp. ‘s 2015 Equity Incentive Plan |
Denver, Colorado
February 28, 2018
/s/ Eide Bailly, LLP